筛选自人卵巢癌细胞系HO8910的干细胞生物学特性分析
[Abstract]:Objective to investigate the biological characteristics of human ovarian cancer cell line HO8910. Methods the stem cells of ovarian cancer cell line HO8910 were subcultured in serum-free medium and HO8910 cells were used as control. The spherical formation ability of the two kinds of cells was observed in vitro, the differentiation ability of the two kinds of cells was observed, the differentiation ability was observed, and the related markers of stem cells were detected. The sensitivity of the two kinds of cells to DDP, doxorubicin and mitoxantrone was detected by drug sensitivity test. The two kinds of cells subcultured in serum-free medium were inoculated into NOD/SCID nude mice to observe their tumorigenesis in vivo. Results the globular formation ability of HO8910 cells in serum-free medium was significantly lower than that of ovarian cancer cells (P 0.05). The positive expression rate of CD133,CD117 in ovarian cancer stem cells before differentiation was significantly higher than that after differentiation. The expression of ABCG2,Nanog,Oct4,BCRP,E-cadherin in ovarian cancer stem cells after differentiation was lower than that before differentiation, but there was no significant difference compared with that before and after differentiation of HO8910 cells. 0.25 渭 g / mL DDP, 0.5 渭 mol / L doxorubicin, 0.05 渭 g / mL mitoxantrone and 0.25 渭 g / mL mitoxantrone on ovarian cancer stem cells for 48 h. The relative activity of ovarian cancer stem cells was higher than that of HO8910 cells. With the increase of the number of stem cells inoculated with 1 脳 103 ovarian cancer stem cells in nude mice, the tumorigenesis rate increased gradually and the tumorigenesis time decreased gradually (P 0.05). Conclusion the ovarian cancer stem cells screened from human ovarian cancer cell line HO8910 have the characteristics of self-renewal and differentiation, tumorigenesis in vivo, high expression of stem cell genes and resistance to chemotherapy, which is in accordance with the theoretical standard of tumor stem cells.
【作者单位】: 徐州医学院;徐州医学院附属医院;
【分类号】:R737.31
【参考文献】
相关期刊论文 前1条
1 闫洪超;于楠;仝建业;陆晓媛;韩秋峪;魏敏;;人卵巢癌HO8910细胞株中干细胞的筛选及生物学特性鉴定[J];江苏医药;2012年10期
【共引文献】
相关期刊论文 前3条
1 陈晓杰;冯笑山;;紫杉醇与奈达铂联合化疗方案不同给药方式治疗晚期卵巢癌的效果比较[J];河南医学研究;2015年04期
2 仝建业;闫洪超;;WWOX基因转染对卵巢癌干细胞增殖的抑制作用及其机制探讨[J];山东医药;2014年14期
3 蒋小芒;赵娜;龙敏;;卵巢癌细胞中CD90~+肿瘤干细胞的生物学特性[J];中国组织工程研究;2015年32期
相关博士学位论文 前1条
1 闫洪超;WWOX基因干预对人卵巢癌干细胞生物学行为的影响[D];山东大学;2014年
【相似文献】
相关期刊论文 前10条
1 秦薇,杨元先,王泽华;端粒酶活性与卵巢癌细胞系药物敏感性的关系[J];肿瘤;2004年01期
2 刘琦,刘春敏,孟奎,姜少军,吴波,石群立,任蕴芳;胆酸钠对人卵巢癌细胞系作用的研究[J];中国实用妇科与产科杂志;2004年11期
3 李晓艳;王泽华;;卵巢癌细胞系敏感株与耐药株中环氧化酶-2的表达研究[J];中国妇幼保健;2006年05期
4 李力,陈心秋,黄薇,唐东平,黎丹戎;耐长春新碱人卵巢癌细胞系的建立和耐药机制的研究[J];广西科学;1998年01期
5 徐明娟,崔英,王昭梅,宋亮年;甾体激素对人卵巢癌细胞系3AO增殖分化的影响[J];上海医学;2001年02期
6 许沈华,牟瀚舟,吕桂泉,朱赤红,羊正炎,高永良,楼洪坤,刘祥麟,程勇,杨文;高低转移人卵巢癌细胞系基因表达谱差异(英文)[J];Chinese Medical Journal;2002年01期
7 白丽霞,赵丽嫣;脱氧氟尿苷逆转人卵巢癌细胞系顺铂耐药的研究[J];中国实用妇科与产科杂志;2003年04期
8 魏素菊,史健,刘义冰,冯威健;拓扑异构酶Ⅰ、Ⅱ抑制剂序贯给药对人卵巢癌细胞系的影响[J];实用肿瘤杂志;2005年02期
9 赵宏伟;田秀珠;张华屏;郭素堂;任连生;赵嘉惠;王波;;不同侵袭潜能卵巢癌细胞系蛋白质谱的比较[J];基础医学与临床;2006年06期
10 徐明娟,崔英,方国恩,宋亮年,王昭梅;糖皮质激素对人卵巢癌细胞系(3AO)的诱导分化作用[J];上海医学;2003年04期
相关会议论文 前10条
1 郑智国;高,
本文编号:2524919
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2524919.html